A Randomized Double-Blind Placebo-Controlled 2-Period Crossover Study to Evaluate Effectiveness of Single-Dose MK0657 in Combination With Levodopa on Motor Symptoms and Dyskinesias in Patients With Parkinson's Disease.

Trial Profile

A Randomized Double-Blind Placebo-Controlled 2-Period Crossover Study to Evaluate Effectiveness of Single-Dose MK0657 in Combination With Levodopa on Motor Symptoms and Dyskinesias in Patients With Parkinson's Disease.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Apr 2014

At a glance

  • Drugs CERC 301 (Primary) ; Levodopa
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 08 May 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 27 Feb 2008 Status changed from recruiting to in progress.
    • 14 Jan 2008 The expected completion date for this trial is now 1 Feb 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top